5 not yet recruiting, 5 recruiting, 1 terminated. 6 Not applicable, 2 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Not yet recruiting 3, Recruiting 3 |
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Continuous Renal Replacement Therapy (CRRT): new trials by email Literature Review of Continuous Renal Replacement Therapy (CRRT) trials Research Report on Continuous Renal Replacement Therapy (CRRT)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Insights Into the Continuous Renal Replacement Therapy to Critical Ill Patients continuous renal replacement therapy - Continuous Renal Replacement Therapy (CRRT), Acute Kidney Injury | Not yet recruiting | University of Alberta | 100000 | 2027-03-31 | 2026-09-09 | |
| Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy mVExUS-guided fluid management - AKI - Acute Kidney Injury, Fluid Balance | Not applicable | Recruiting | Chulalongkorn University | 126 | 2026-09-30 | 2026-10-05 |
| Effect of High Versus Standard Protein Intake in Critically Ill Patients With Acute Kidney Injury Requiring Continuous Renal Replacement Therapy High protein group, Standard protein group - Acute Kidney Failure Stage 3, Continuous Renal Replacement Therapy (CRRT) | Not applicable | Recruiting | Chulalongkorn University | 56 | 2026-09-27 | 2026-10-07 |
| Prospective Analysis of Arteriovenous Access (AVA) Use in Continuous Renal Replacement Therapy: A Feasibility Project Cannulation of permanent dialysis access, for the purpose of delivering continuous renal replacement therapy. - Continuous Renal Replacement Therapy (CRRT), End Stage Kidney Disease (ESRD) | Not applicable | Not yet recruiting | East Carolina University | 50 | 2026-07-27 | 2026-07-06 |
| Nafamostat Mesylate Versus Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Sepsis-Associated Acute Kidney Injury Citrate anticoagulation, Nafamostat Mesylate - Sepsis, Acute Kidney Injury | Phase 4 | Not yet recruiting | Jianfeng Xie | 1162 | 2026-06-10 | 2026-06-03 |
| Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU) Nafamostat Low-Dose Group, Nafamostat High-Dose Group - Continuous Renal Replacement Therapy (CRRT) | Phase 2 | Recruiting | Zhujiang Hospital | 92 | 2026-04-07 | 2026-04-14 |
| Continuous Renal Replacement Therapy Doses in Critically Ill Patients With Acute Kidney Injury continuous renal replacement therapy - Renal Replacement Therapy for Acute Kidney Injury in ICU, Continuous Renal Replacement Therapy (CRRT) | Not applicable | Not yet recruiting | Fundacion Clinic per a la Recerca Biomédica | 100 | 2025-08-01 | 2025-07-17 |
| Ultrasound-Guided Microbubble Removal and Filter Lifespan During CRRT: A Pilot Crossover Study Ultrasound-Guided Microbubble Clearance During Circuit Priming - Acute Kidney Injury, Continuous Renal Replacement Therapy (CRRT) | Not applicable | Not yet recruiting | First Affiliated Hospital of Wannan Medical College | 40 | 2025-06-30 | 2025-06-05 |
| Validation of a Regional Citrate Anticoagulation Protocol in Critically Ill Patients on Continuous Renal Replacement Therapy continuous renal replacement therapy - Acute Kidney Injury, ICU Patients | Not applicable | Recruiting | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 43 | 2024-11-24 | 2026-04-07 |
| Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory - Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT) | Phase 3 | Recruiting | Vantive Health LLC | 40 | 2024-07-12 | 2026-10-05 |
| Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT) Prismocitrate 18, No Anticoagulation - Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT) | Phase 3 | Terminated | Vantive Health LLC | 34 | 2016-09-27 | 2025-07-22 |
Acute Kidney Injury (8) · Critical Illness (1) · Kidney Failure, Chronic (1) · Sepsis (1) · Shock (1)
Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Kidney Diseases (9) · Male Urogenital Diseases (9) · Renal Insufficiency (9) · Urogenital Diseases (9) · Urologic Diseases (9) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Disease Attributes (2) · Chronic Disease (1) · Infections (1) · Inflammation (1) · Renal Insufficiency, Chronic (1) · Systemic Inflammatory Response Syndrome (1)
Continuous Renal Replacement Therapy (3) · nafamostat (2) · Population Groups (1)
Chulalongkorn University (2) · Vantive Health LLC (2) · East Carolina University (1) · First Affiliated Hospital of Wannan Medical College (1) · Fundacion Clinic per a la Recerca Biomédica (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Jianfeng Xie (1) · University of Alberta (1) · Zhujiang Hospital (1)
United States (3) · Canada (2) · Thailand (2) · China (1) · Spain (1)
Alejandra Espinosa Guerrero, Clinical Operations Head (1) · Armando F Rodriguez Lopez, MD (1) · Iskra Myers, MD (1) · Oleksa Rewa (1) · Yingzi Huang (1) · Zhanguo Liu, M.D.PhD (1)